Erasca ERAS
NASDAQ ERAS
$14.74 +0.16 (+1.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

Erasca (ERAS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Erasca (ERAS) posted Return on Capital Employed [ROCE] of -73.01% for Q2 2026, down 38.90 percentage points from -34.11% a year earlier and down 0.08 percentage points from the prior quarter.

Analysis

Erasca (ERAS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Erasca's Return on Capital Employed [ROCE] came in at -33.48%, up 9.53 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of +10.05 percentage points (FY2021 to FY2025).
  • In prior years, Erasca's Return on Capital Employed [ROCE] was -43.01% in FY2024 (-10.02 pp), -32.99% in FY2023 (+20.86 pp), -53.86% in FY2022 (-10.33 pp) and -43.53% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of -4.82 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2024, with a gain of 25.19 percentage points; the weakest was Q2 2026, with a drop of 38.90 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -72.93% (Q1 2026), -37.10% (Q4 2025) and -35.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Erasca 4.61 Bn 4.61 Bn - -73.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -73.01%
Mar 31, 2026 -72.93%
Dec 31, 2025 -37.10%
Sep 30, 2025 -35.63%
Jun 30, 2025 -34.11%
Mar 31, 2025 -38.22%
Dec 31, 2024 -37.08%
Sep 30, 2024 -35.74%
Jun 30, 2024 -41.41%
Mar 31, 2024 -40.68%
Dec 31, 2023 -37.13%
Sep 30, 2023 -60.93%
Jun 30, 2023 -57.57%
Mar 31, 2023 -53.25%
Dec 31, 2022 -57.28%
Sep 30, 2022 -33.60%
Jun 30, 2022 -34.15%
Mar 31, 2022 -30.36%
Dec 31, 2021 -25.72%
Sep 30, 2021 -46.40%
API Access

Erasca Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ERAS&period=max&api_key=YOUR_API_KEY